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Two circulations perfuse the placental barrier, the maternal or
uterine on one side and the fetal or umbilical on the other.
This barrier consists of two specific membranes, the maternal
facing, microvillous (MVM) or apical membrane and the fetal
facing or basal membrane (BM). As human gestation advances
the surface area of the microvillous membrane increases.
Though late in pregnancy, this increase is not of comparable
rate to the growth rate of the fetus, supporting the concept that
during later pregnancy the increasing physiological needs of
the fetus are achieved by multiple functional changes in the
total placental exchange capacity. One component of this
capacity is amino acid transport. Both placental membranes
have a range of active energy dependent amino acid transport
systems [1]. These systems act in a coordinated manner to
transport amino acids from both circulations into the
trophoblast, as well as out of the trophoblast, into circulation.
In addition to surface area, many other factors also influence
overall activity. Maternal circulating concentrations of amino
acids also play a major role in regulating umbilical uptake,
where the transport of any given amino acid from placenta to
fetus is considered a function of both its own maternal
concentration and the maternal concentration of inhibitory
amino acids [2]. Additionally, electrical gradients exist over the
placenta, across which transport systems operate, indicative of
the energy requirement of these systems [3]. It is important to
remember that the trophoblast acts not only as a conduit for
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metabolic rate, utilizing amino acids for its own metabolic
functions, which include hormone and steroid production as
well as waste removal from fetal circulation [4].
To understand the overall functional capacity of the
placental barrier, attempts to consider all of the above
components need to be made, especially when investigating
how adverse situations may impact upon the developmental
and functional capacity of the placenta. Specifically, in the
situation of fetal growth restriction (FGR), there is in vivo and
in vitro data to demonstrate significant changes in the placental
surface area/permeability constants [5], its amino acid trans-
port activity in vitro [6e8], and in vivo [9e12]. The FGR
placenta has decreased total villous surface area, indicating that
morphometric changes in vascularization may contribute to the
overall reduction in placental diffusional transport capacity.
Thus, both decreased surface area for diffusional exchange for
compounds such as oxygen and reductions in the number of
specific nutrient transporters and their activities may contrib-
ute to a global reduction in nutrient transport in FGR
pregnancies.
The purpose of this workshop was to deal with a range of
work representing aspects of amino acid transport systems,
including their locations, their substrates and their activities,
from both in vitro and in vivo settings. However, rather than
act as a forum for mini reviews, this workshop was designed
for presenters to put forward experimental inconsistencies in
some of these aspects for general discussion and input from the
gathered group. The aim, at the end of the workshop, was to
have a consensus of where specific placenta amino acid
transporters may be located, what their substrates and their
individual activities may be, how they might interact with one
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situation of FGR.
HUMAN INFUSION STUDIES – DIFFERENCES
IN CERTAIN AMINO ACID UPTAKES
(A. M. MARCONI)
In pregnancy, for the majority of amino acids, concentrations
are higher in fetal circulation than in maternal circulation. In
FGR, the maternal concentrations of most essential amino
acids are significantly higher than in appropriate-for-gesta-
tional-age pregnancies, closer to fetal concentrations. This
observation, coupled with lower fetal amino acid concen-
trations in FGR, trending towards maternal concentrations,
leads to significantly lower fetalematernal differences [13].
These significantly lower fetalematernal concentration differ-
ences occur independently of the degree of severity [13]. It has
been of clinical interest to see if in human pregnancies
complicated by FGR, the maternal intravenous infusion of
amino acids can increase fetal amino acid concentrations and
umbilical uptake. In a maternal infusion experiment using
a solution of amino acids, the umbilical vein concentrations of
valine, methionine, isoleucine, leucine, phenylalanine, argi-
nine, serine, glycine, and proline were elevated [11]. Umbilical
venoarterial differences of amino acid per mole of oxygen, as
a in vivo measure of amino acid uptake, for leucine, isoleucine,
methionine, arginine, glycine, serine, and proline were
elevated, but not for lysine, histidine, threonine, valine, and
phenylalanine [11]. These data suggest that the umbilical
uptake of several of the essential amino acids may be reduced
in FGR pregnancies compared with AGA pregnancies.
Indeed, it has been demonstrated that the fetomaternal
enrichment ratios of leucine and phenylalanine are significantly
reduced in vivo in FGR pregnancies [10]. Additionally these
human data highlight the importance of amino acid compe-
tition effects. In pregnant sheep studies, the transport of any
given amino acid from placenta to fetus is a function of both its
own maternal concentration and the maternal concentration of
inhibitory amino acids [2]. These effects may also exist in the
human placenta and if so may explain why in the human FGR
pregnancy, leucine and say arginine uptake appear to be
enhanced at the expense of valine, lysine, histidine and other
essential amino acids. Discussion of these data focused around
the interactions of the apical yC and the basal yCL transport
systems and their transport properties, and possible inhibition
characteristics, highlighting the need to maybe redesign the
amino acid infusion to take into account possible transport
system and amino acid inhibitory effects. The infusate should
aim at improving fetal nutrition to produce percent concen-
tration increases in maternal concentrations that either are of
similar value or are biased in favor of the amino acids with
weak inhibitory power. Finally, the discussion also dealt with
the heterogeneous nature of FGR and the need to carefully
characterize FGR groups in considering certain treatments,
especially as there have been conflicting reports in the
literature concerning the value of supplementation. Attentionto uniformly classifying FGR groups is needed as different
placental function, based on the severity of FGR, may result in
different amino acid transport function and ultimate umbilical
supply to the developing fetus.
THE VALUE OF ISOFORM IDENTIFICATION –
QUESTIONS OF THE ROLES OF
INDIVIDUAL ISOFORMS WITHIN
THE TROPHOBLAST (C. H. SMITH)
In isolated placental membranes, system yC activity is present
in both MVM and BM, though the fraction of yC uptake is
greater in MVM [14]. Activity in isolated BM is essentially
completely inhibited by neutral amino acids and sodium,
which suggests that it is likely to be inactive in utero. The
cloning of trophoblast hCAT-1 and hCAT-2B, the compo-
nents of system yC activity, has allowed molecular and cellular
investigation of mechanisms responsible for these membrane
differences [15]. Expressed in Xenopus oocytes, hCAT-1 is
completely inhibited by increasing concentrations of neutral
amino acids such as alanine, whereas hCAT-2B activity is only
partially inhibited. These results suggest that hCAT-1 and -2B
may be primarily expressed in trophoblast BM and MVM,
respectively [16]. Transfection studies using the MDCK
epithelial cell model support this concept of differential
distribution of the isoforms between the two epithelial
membranes [17]. In summary, these investigations highlight
the need to take into account isoform characteristics and
expression in understanding overall transport system function
in the two trophoblast surface membranes. By way of
conclusion discussion was expanded to consideration of the
protein chain location, function and regulation of some of the
other documented placental amino acid systems, A, L, ASC,
yCL and b0,C.
REGULATION OF PLACENTAL AMINO
ACID TRANSPORT SYSTEMS IN
FGR – RESPONSE TO ADAPTATION
FAILURE OR INSULT (J. D. GLAZIER)
The transport systems A, L and yCL play a major role in
transporting amino acids into and out of the placenta. Each
system has defined protein associations, monomeric or
heterodimeric, different substrates and sodium requirements
[4,18]. Monomeric systems differ from heterodimeric systems
in that monomeric systems are functional as a single protein in
the cell membrane, while a heterodimeric system is one that to
be functional requires the co-expression of a light chain and
a heavy chain. Currently there are two well documented heavy
side chains, the 4F2HC and the rBAT [19]. System A is
a monomeric system, and consists of three different isoforms
SNAT 1 (ATA-1), SNAT 2 (ATA-2) and SNAT 4 (ATA-3),
in both the human and rat placenta. Each isoform of system A
displays different affinities for the short chain neutral amino
acids, including alanine, glycine and glutamine and requires
sodium for its activity. In comparison, system L is a hetero-
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activity, LAT-1 and LAT-2. These proteins, in concert with
the heavy chain, 4F2HC, have a broad specificity for neutral
amino acids with bulky side chains including the essential
amino acids, leucine, isoleucine, tryptophan, and phenylala-
nine. Unlike system A, sodium is not required for their
activity. The yCL also is a heterodimeric system transporting
both neutral and cationic amino acids through the expression
of one of its light chains, yCLAT-1 or yCLAT-2. It is
interesting to note that while sodium is required for the
transport of the neutral amino acids, it is not required for the
cationic amino acids arginine and lysine. These three systems
exist on both membranes and have been studied in a range of
unfavorable situations, including FGR [6,7,20] and situations
of hypoxia [21], where reductions in activity are reported. One
of the interesting observations of these studies is that the major
deficits of activity in FGR is not a change in affinity, but
reductions in the Vmax of these systems of between 30 and
60% [6,7]. Possible explanations of this reduced activity
include induced changes in mRNA transcription, translational
efficiency, possible alterations in the expression of protein
particularly in aspects of trafficking and recruitment from
intracellular compartment. Finally the question of a possible
decreased catalytic turnover might also be considered where
there may be post-translational modifications and the existence
of as yet unreported polymorphisms.
AMINO ACID TRANSPORT SYSTEM
FUNCTION – DIFFERENCES BETWEEN
IN VIVO AND IN VITRO OBSERVATIONS
(D. A. NOVAK)
The amino acid transport system A is found in both the apical
and basal membranes of the trophoblast, and as mentioned
earlier represents a monomeric transport system, comprised of
three isoforms, SNAT-1, SNAT-2 and SNAT-4. When
pregnant rats are fed a low-protein (5% casein), isocaloric
diet when compared with dams pair-fed a control (20% casein)
diet, diminished placental/fetal growth is observed. Addition-
ally, a significant reduction in nutrient transfer to the fetus is
suggested as the fetomaternal serum amino acid ratios are
significantly reduced [22]. Supporting this observation, in
vitro apical transport is reduced by approximately 50% and
basal membrane transport by 70%, and the expression of
SNAT-2 mRNA is diminished by 60% as compared to
controls (unpublished data). In other experiments, where
a slightly less restrictive diet is fed (8% casein), system A
activity is still impaired. This impairment is measured in vivo
as a reduction in the fetal accumulation of MeAIB (a system
specific substrate, particularly for SNAT-2), following a ma-
ternal injection near term. Interestingly, the permeability of
the placenta appears to be unaltered as the fetal/placental and
fetal/serum inulin ratios are unaltered, suggesting that these
observed changes are related to changes in transport system
number and or activity. Unexpectedly, quantitative PCR
results from these animals show an almost two-fold increase inSNAT-1 and SNAT-2 mRNA and no change in SNAT-4.
However, when apical vesicle uptake studies are conducted,
the 8% protein placenta have significantly reduced sodium
dependent activity by approximately 30%, in line with the
original in vivo observations of a reduced transport to the
fetus. These studies together with the 5% protein diet
experiments, demonstrate diminished placental/fetal growth
and apical membrane system A mediated uptake, despite
a difference in the level of protein restriction. However,
SNAT-2 mRNA expression is diminished in the 5% group,
but enhanced in the 8% group, despite a similar phenotype.
Discussion in the workshop moved to possible reasons for this
difference covering such possibilities as the interaction of
starvation regulation genes analogous to Gln3 [23], regulating
members of the system A family and the concept that
regulation of system A isoforms may be stress regulated,
though with different responses between the three isoforms.
FGR RELATED CHANGES IN
TRANSPORTER SYSTEMS – SEVERITY
OF FGR (T. R. H. REGNAULT)
One of the recent observations of studies in FGR is the
heterogeneous nature of FGR. This is particularly important
when considering possible treatments, as it is becoming
apparent that not one magic bullet will assist all FGR
outcomes and that treatments need to be designed for
specifically tight groupings of FGR. In the ovine hyperthermic
stress induced model of FGR, a sub-set of FGR has been
observed [12]. This group of animals has been exposed to
environmental stress, that normally reduces placental and fetal
weights by 40e60% [24], though for these animals, while
placenta and fetal weights are reduced, they are only reduced
by approximately 25%. In these moderately FGR (mFGR)
animals, umbilical oxygen, glucose and the essential amino acid
uptakes are not different from control animals, whilst the
severe FGR (sFGR) animals have significant reductions for all
these substrates. Possible explanations for this difference
appear in two areas. Firstly, the placental diffusional exchange
capacity of the sFGR fetuses is significantly reduced,
compared to control and mFGR fetuses, suggesting changes
in placental permeability and surface area, acting as an
impediment to control value uptakes per unit of fetal weight.
Secondly, when examining the mRNA expression of system L
light chain components, LAT-1 and LAT-2, it is observed
that while concentrations in sFGR are not different from
control placentae, mFGR concentrations are significantly
elevated. This suggests that in the sFGR placenta there may
be an up-regulation of specific transport systems, maybe to
attempt overcome the reduction in calculated diffusional
exchange capacity, though this is unable to reverse the total
decreased amino acid uptake observed in these animals. The
other fact highlighted is that in the mFGR placenta, there may
be a successful up-regulation of transport system mRNA, to
maintain umbilical amino acid uptake. Further studies
considering histological analysis of these placentae, together
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help the interpretation of these data, and assist in our
understanding of the possible different placental outcomes of
FGR pregnancies.
PLACENTAL SYSTEM A AND FGR –
IS DOWN-REGULATION A ROBUST
MARKER FOR FGR? (T. JANSSON)
Clinically, the identification of babies subjected to intrauterine
under-nutrition is critical since FGR is associated with
perinatal complications as well as adult disease. Birth weight
is a relatively poor indicator of the adequacy of intrauterine
nutrition and defining FGR on birth weight only is unreliable.
Although the introduction of repeated umbilical Doppler flow
measurements and intrauterine fetal weight estimates have
improved the diagnosis of FGR the need for additional
diagnostic tools remains. The recent demonstration that FGR
is characterized by specific alterations in a number of placental
nutrient transporters may offer a novel approach for diagnosis.
In particular, decreased activity of system A has been
suggested to represent a marker for FGR since system A
activity has been shown to be down-regulated in microvillous
plasma membranes isolated from FGR placentas in several
studies [7,25,26]. However, some observations suggest a rather
complex relationship between placental system A activity and
fetal growth. First, within the normal range of birth weights
MVM system A activity is inversely correlated to birth weight,
i.e., a smaller baby has a higher placental system A activity
[27]. Second, in the study of Jansson et al. [26] MVM system
A was found to be reduced only in preterm FGR placentas
whereas term FGR was characterized by unaltered transport
activity. Third, MVM system A activity in accelerated fetal
growth in association to diabetes has been reported to be either
increased [28] or decreased [29]. In line with this latter study,
preliminary data were presented to suggest that also in certain
animal models down-regulation of placental system A may be
a marker for accelerated fetal growth rather than FGR. The
system A transporter is highly regulated. It is suggested that
placental system A activity in vivo is affected by factors like
maternal nutrition, ethnicity, smoking, diabetes control and
body-mass-index that may interact in a complex fashion
resulting in a placental system A activity that is not always
correlated with fetal growth. It is concluded that although
measurements of placental transporter activity and expression
may represent a sensitivemarker for FGR it is possible that other
transport systems in addition to system A have to be assessed.
CONCLUSIONS
Each presenter put forward experimental inconsistencies in
aspects of placental amino acid transport, with an emphasis
upon transport in FGR, for general discussion and input from
the gathered group. While the time permitted did not allow for
in depth consensuses to be reached on many of the discussed
topics, the workshop did provide a unique opportunity forinvestigators to be reminded of the types and complexities of
the different systems studied in this field of research. As
a result of these discussions it was agreed to establish
a Placental Amino Acid Transport Systems Web page, where
information and ideas can be publicly available.
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